Stock listing
42Z Stock Price, News, Filings & Events — Revolution Medicines, Inc.
Selected listing: 42Z · GETTEX · EUR · DE
This page tracks Revolution Medicines, Inc.'s 42Z:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 42Z:GETTEX. 42Z:GETTEX is the stock-level entry point for investors researching Revolution Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 42Z:GETTEX
- Asset type
- Stock
- Market cap
- $43.68B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- GETTEX
- Currency
- EUR
Revolution Medicines, Inc. 42Z:GETTEX stock context
This page tracks Revolution Medicines, Inc.'s 42Z:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 42Z:GETTEX. 42Z:GETTEX is the stock-level entry point for investors researching Revolution Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Revolution Medicines, Inc.
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
September 14, 2026
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
September 2, 2026
U.S. FDA Approves Revolution Medicines' RASONQUE (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 27, 2026
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 26, 2026
Revolution Medicines and BeOne Medicines Announce Clinical Development and Regional Commercialization Collaboration
August 11, 2026
Revolution Medicines, Inc. earnings calls
Revolution Medicines, Inc. (RVMD) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Revolution Medicines, Inc.
Revolution Medicines, Inc. investor report
Review AI stock analysis and investor report context for 42Z:GETTEX.
Revolution Medicines, Inc. company profile
View the public company page for Revolution Medicines, Inc. on 6ix.
Revolution Medicines, Inc. news
Read company news and market updates connected to Revolution Medicines, Inc..
Revolution Medicines, Inc. investor events
Find investor webinars, events, and replay context for Revolution Medicines, Inc..
Alternate listings
RVMD:NASDAQ
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
A2PYWG:LSX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
1RVMD:MIL
IT · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
42Z:TRADEGATE
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
RVMD:BX
CH · CHF
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
RVMD:BOATS
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
A2PYWG:LS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
RVMD:BMV
MX · MXN
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
42Z:DUS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
42Z:FWB
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
42Z:HAM
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.
42Z:MUN
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 42Z:GETTEX.